BioSig Technologies, Inc. (NASDAQ:BSGM) Short Interest Up 38.4% in April

BioSig Technologies, Inc. (NASDAQ:BSGM) was the recipient of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 961,600 shares, an increase of 38.4% from the March 31st total of 694,900 shares. Approximately 10.4% of the shares of the stock are short sold. Based on an average daily volume of 1,150,000 shares, the days-to-cover ratio is presently 0.8 days.

Hedge Funds Weigh In On BioSig Technologies

A number of institutional investors have recently modified their holdings of the stock. Warberg Asset Management LLC increased its holdings in shares of BioSig Technologies by 93.9% in the third quarter. Warberg Asset Management LLC now owns 63,856 shares of the company’s stock valued at $31,000 after purchasing an additional 30,928 shares in the last quarter. PFG Investments LLC boosted its position in BioSig Technologies by 79.3% in the 3rd quarter. PFG Investments LLC now owns 143,600 shares of the company’s stock valued at $70,000 after buying an additional 63,500 shares during the last quarter. Advisor Resource Council increased its stake in shares of BioSig Technologies by 19.6% in the 3rd quarter. Advisor Resource Council now owns 1,077,906 shares of the company’s stock valued at $527,000 after buying an additional 176,700 shares during the period. Finally, Armistice Capital LLC bought a new stake in shares of BioSig Technologies during the fourth quarter worth $2,660,000. 7.16% of the stock is owned by institutional investors.

BioSig Technologies Trading Down 2.2 %

Shares of BioSig Technologies stock traded down $0.03 during trading on Monday, reaching $1.34. The company’s stock had a trading volume of 57,253 shares, compared to its average volume of 919,760. The stock has a 50-day moving average price of $0.86 and a two-hundred day moving average price of $2.46. The stock has a market capitalization of $15.01 million, a P/E ratio of -0.28 and a beta of 1.21. BioSig Technologies has a one year low of $0.26 and a one year high of $16.50.

About BioSig Technologies

BioSig Technologies, Inc, together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures.